Literature DB >> 33726530

Trauma and donation after circulatory death: a case series from a major trauma center.

Alessandro Circelli1, Etrusca Brogi2, Emiliano Gamberini1, Emanuele Russo1, Marco Benni1, Giovanni Scognamiglio1, Andrea Nanni1, Federico Coccolini3, Francesco Forfori2, Paola Fugazzola4, Luca Ansaloni4, Piergiorgio Solli5, Fabrizio Di Benedetto6, Matteo Cescon7, Vanni Agnoletti1.   

Abstract

Even with encouraging recipient outcomes, transplantation using donation after circulatory death (DCD) is still limited. A major barrier to this type of transplantation is the consequences of warm ischemia on graft survival; however, preservation techniques may reduce the consequences of cardiac arrest and provide better organ conservation. Furthermore, DCD in trauma patients could further expand organ donation. We present five cases in which organs were retrieved and transplanted successfully using normothermic regional perfusion (NRP) in trauma patients. Prompt critical care support and surgical treatment allowed us to overcome the acute phase. Unfortunately, owing to the severity of their injuries, all of the donors died. However, the advanced and continuous organ-specific supportive treatment allowed the maintenance of general clinical stability and organ preservation. Consequently, it was possible to retrieve and transplant the donors' organs. Death was ascertained in accordance with cardio-circulatory criteria, which was followed by NRP. We consider that DCD in trauma patients may represent an important source of organs.

Entities:  

Keywords:  Organ donation; controlled donation after circulatory death; kidney transplantation; liver transplantation; lung transplantation; normothermic regional perfusion; trauma; trauma donors

Mesh:

Year:  2021        PMID: 33726530     DOI: 10.1177/03000605211000519

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  1 in total

1.  Changes in the Deceased-Donor Trend in Korea: Establishment of Regional Trauma Centers and KODA.

Authors:  Jeong-Moo Lee
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.